• Tacalcitol monohydrate: Applied Research Workflows

  2026-09-04

  Tacalcitol monohydrate supports distinct workflows in keratinocyte biology, NGF induction, and colorectal cancer research. This guide converts reported concentration windows into practical dosing, combination-treatment, validation, and troubleshooting strategies while clearly separating established evidence from exploratory assay design.

• 7-dehydro Cholesterol: DHCR7 Research Guide

  2026-09-03

  7-dehydro Cholesterol, also called 7-dehydrocholesterol, is the endogenous DHCR7 substrate that connects cholesterol biosynthesis research with vitamin D3 synthesis research and UVB photobiology studies. The C3922 product is a research-grade sterol for controlled sterol-flux, photochemical, oxidative, and disease-model experiments.

• SW033291: A Translational Lever for Regeneration

  2026-09-03

  SW033291 is a potent 15-PGDH inhibitor that elevates endogenous prostaglandin E2 and offers a mechanistically coherent platform for studying tissue repair, hematopoiesis, and muscle regeneration. This thought-leadership article connects biochemical potency with experimental design and translational strategy, while placing recent evidence from semaglutide-associated muscle loss in appropriate context. The central message is strategic: 15-PGDH inhibition is promising not as a universal regenerative treatment, but as a tissue- and context-dependent tool for testing how prostaglandin signaling reshapes repair niches.

• 740 Y-P for PI3K/AKT Research Workflows

  2026-09-02

  740 Y-P is a cell-permeable PI 3-kinase activator for controlled interrogation of PI3K/AKT signaling, with practical value in vesicular trafficking research, cancer research, neuronal cell survival, and stress-response models. This guide connects product handling with assay design, pathway validation, and the mechanistic insights of a recent BMSC autophagy study.

• PPP1R3G–PP1γ Control of RIPK1 Cell Death

  2026-09-02

  Du and colleagues identify PPP1R3G–PP1γ as a phosphatase module that removes inhibitory RIPK1 phosphorylation and enables RIPK1-dependent apoptosis and type I necroptosis. Their genetic, biochemical, chemical, and in vivo evidence positions RIPK1 dephosphorylation as a regulatory checkpoint linking TNF signaling to inflammatory cell death.

• TH287 MTH1 Inhibitor: Radiosensitization Workflow

  2026-09-01

  TH287 combines high-potency MTH1 inhibition with a practical timing strategy for studying radiation response in castration-resistant prostate cancer models. This workflow connects oxidative stress-induced DNA damage to apoptosis, cell-cycle arrest, and cancer cell selective cytotoxicity while emphasizing controls that distinguish true radiosensitization from assay artifacts.

• Pam3CSK4 and the Neuro-Immune Future of Inflammation

  2026-09-01

  Pam3CSK4 offers a defined TLR1/2 perturbation for studying immune activation, allergic inflammation, and neuro-immune regulation. By connecting receptor-level control with recent evidence for TRPV1-driven anti-inflammatory reflexes, this article outlines a practical strategy for more mechanistic and translationally relevant inflammation models.

• RESTRICT-seq Maps Epigenetic Dependencies in SCC

  2026-08-31

  The bioRxiv preprint introduces RESTRICT-seq as a time-gated CRISPR screening framework for distinguishing dependencies that arise during squamous cell carcinoma resistance from those required to maintain the resistant state. Its main implication is methodological: temporal control may expose epigenetic vulnerabilities that conventional endpoint screens overlook, although the preprint’s findings should be interpreted pending peer review and full validation.

• Hyperforin Targets Dlat–Trpv3 Thermogenesis

  2026-08-30

  The reference study identifies a non-canonical Dlat–Trpv3–Ca2+–CaMKKβ–AMPK pathway through which hyperforin stimulates adipose thermogenesis and reduces obesity-related phenotypes in mice. Its combination of oral efficacy, pharmacokinetic analysis, genetic validation, and cardiac-safety assessment provides a useful framework for developing thermogenic interventions outside the conventional β3-adrenergic receptor pathway.

• Biotin Azide Workflows for Fzd5 Signaling Assays

  2026-08-29

  Biotin Azide converts terminal-alkyne chemistry into a practical route for selective biomolecule capture, detection, and interaction analysis. This guide adapts the workflow to mechanistic questions raised by Frizzled5 cholesterol sensing while emphasizing controls, cleanup, and troubleshooting.

• Thymoquinone: A Mechanistic Guide to Cardiotoxicity

  2026-08-29

  Thymoquinone is more than an antioxidant candidate: its value in cardiotoxicity research depends on connecting cardiac function, ferroptosis, redox biology, and pathway-specific readouts. This guide translates recent mouse evidence into a rigorous assay-interpretation framework.

• Realgar, Ornithine, and Astrocyte Glycolysis

  2026-08-28

  A 2025 Advanced Science study connects realgar-induced liver injury with CNS toxicity through an OTC–ornithine–ZBTB7A pathway that suppresses astrocyte glycolysis. Its multi-model design shows how hepatic disruption of a urea cycle intermediate may amplify arsenic-associated metabolic and behavioral injury, while identifying testable readouts for liver–brain axis research.

• DON Hepatotoxicity: Mitophagy and Nrf2 Failure

  2026-08-28

  The reference study proposes that deoxynivalenol (DON) causes liver injury through a coupled process: excessive PINK1/Parkin-mediated mitophagy damages mitochondria while suppression of the p62-Keap1-Nrf2 pathway weakens antioxidant defense. Its mouse and AML-12 cell experiments use pharmacological, genetic, and rescue approaches to connect mitochondrial stress with apoptosis, oxidative stress, inflammation, and lipid dysregulation.

• TET2 Metabolite Binding: Protocol and Findings

  2026-08-27

  Zhang, Cheng, and Ye present an integrated workflow that combines purified human TET2CD activity assays with saturation transfer difference NMR to distinguish metabolite binding from functional regulation. The protocol validates known TET2 activators and inhibitors while providing a practical route for discovering additional regulatory metabolites such as glyoxylate.

• Dynamically Covalent LNPs for CNV Gene Editing

  2026-08-27

  Cao and colleagues engineered dynamically covalent lipid nanoparticles to co-deliver Cas9 mRNA and a VEGFA-targeting guide RNA for transient genome editing in choroidal neovascularization. Their redox-responsive lipidoid design improved intracellular cargo release and produced sustained CNV suppression after a single intravitreal administration in mice, highlighting a nonviral alternative to repeated anti-VEGF treatment.

456 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page